Gore Mitchell R, Zanation Adam M
Department of Otolaryngology-Head and Neck Surgery, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599-7070, USA.
Arch Otolaryngol Head Neck Surg. 2009 Oct;135(10):1030-4. doi: 10.1001/archoto.2009.143.
OBJECTIVE: Esthesioneuroblastoma (ENB) is an uncommon tumor of the sinonasal region with a 20% rate of neck metastases. To our knowledge, the rate of neck metastases occurring 6 or more months after diagnosis has not been well characterized. The rate of successful salvage of these late neck metastases, defined in this study as disease-free survival for at least 1 year, has not been previously reported. DESIGN: Meta-analysis examining 33 articles published since 1990. PATIENTS: A total of 678 patients with ENB with 79 patients with neck metastases occurring 6 or more months after the initial diagnosis. INTERVENTIONS: Patients were grouped according to treatment with surgery, radiotherapy, or combined surgery and radiotherapy. MAIN OUTCOME MEASURES: The rate of successful salvage of late neck metastases, defined as disease-free survival for at least 1 year, was compared for the 3 treatment groups. RESULTS: The rate of cervical metastases was 20.2%, with a 12.4% rate of late neck metastases. The combined successful salvage rate for late neck metastases with surgery, radiation, or combined therapy was 31.2%. An odds ratio (OR) analysis revealed that surgery plus radiation provided a statistically significant increase in the rate of successful salvage in patients with late neck metastases, with an OR of 8.6 vs single modality therapy and a number-needed-to-treat of 3. We found no difference in the OR for successful salvage for surgery alone vs radiation alone (OR, 1.5). CONCLUSION: Treatment of neck metastases occurring 6 or more months after an initial diagnosis of ENB with combined surgery and radiotherapy provides a statistically significant survival advantage vs single-modality therapy.
目的:嗅神经母细胞瘤(ENB)是一种鼻窦区域的罕见肿瘤,颈部转移率为20%。据我们所知,诊断后6个月或更长时间出现颈部转移的发生率尚未得到充分描述。这些晚期颈部转移的成功挽救率,在本研究中定义为无病生存至少1年,此前尚未见报道。 设计:对1990年以来发表的33篇文章进行荟萃分析。 患者:共有678例ENB患者,其中79例在初次诊断后6个月或更长时间出现颈部转移。 干预措施:根据手术、放疗或手术联合放疗进行分组治疗。 主要观察指标:比较3个治疗组晚期颈部转移的成功挽救率,定义为无病生存至少1年。 结果:颈部转移率为20.2%,晚期颈部转移率为12.4%。手术、放疗或联合治疗晚期颈部转移的联合成功挽救率为31.2%。比值比(OR)分析显示,手术加放疗使晚期颈部转移患者的成功挽救率有统计学意义的提高,OR为8.6,而单模式治疗为1,需治疗人数为3。我们发现单纯手术与单纯放疗的成功挽救OR无差异(OR,1.5)。 结论:对于初次诊断ENB后6个月或更长时间出现的颈部转移,手术联合放疗的治疗与单模式治疗相比,具有统计学意义的生存优势。
Arch Otolaryngol Head Neck Surg. 2009-10
Int J Radiat Oncol Biol Phys. 2011-6-15
J Craniomaxillofac Surg. 2008-1
Otolaryngol Head Neck Surg. 2007-6
J Otolaryngol. 2000-12
Eur Arch Otorhinolaryngol. 2010-8-13
Lancet Oncol. 2001-11
Laryngoscope. 2003-1
Virchows Arch. 2024-4
J Neurol Surg Rep. 2023-8-4
J Neurol Surg B Skull Base. 2020-10-5
Int Forum Allergy Rhinol. 2019-6-28
J Neurol Surg B Skull Base. 2018-6
J Neurol Surg B Skull Base. 2017-2